Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 9Radiotherapy 5Rituximab 4Peripheral Blood Stem Cell Transplantation 4Cyclosporine 4fludarabine phosphate 3Melphalan 3Indium 3Filgrastim 3Dexamethasone 3sargramostim 2epratuzumab 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Metronidazole 2Lym-1 monoclonal antibody 2Lenalidomide 2Interferon-alpha 2Idarubicin 2Etoposide 2Cytarabine 2Clarithromycin 2Cisplatin 2Busulfan 2Antilymphocyte Serum 2Amoxicillin 2motesanib diphosphate 1ledipasvir, sofosbuvir drug combination 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, B-Cell, Marginal Zone × denileukin diftitox × Clear all
NCT00026429 2013-12-18

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡